Monitoring and Follow-Up Establish a structured monitoring schedule: Monthly visits during dose titration and the first 6 months Quarterly visits once stable, assessing weight, tolerability, and metabolic parameters Annual comprehensive evaluation including lipid panel, HbA1c (if diabetic), liver function tests, and cardiovascular risk assessment Regular monitoring allows early identification of plateaus, adverse effects, or emerging medical issues that may require intervention
To complement your bodys unique needs, your treatment may also include ingredients like Cyanocobalamin (Vitamin B12) to support energy levels, or L-Carnitine to enhance fat metabolism and preserve lean muscle mass
Ozempic (semaglutide) is an injectable GLP-1 agonist that was initially approved to treat Type 2 diabetes
Obesity is often associated with a myriad of health complications, including cardiovascular disease, hypertension, and even certain types of cancer
That gap may finally be closing
Mougiakakos, D